October 17, 2013

Prasco Labs will distribute an authorized generic for reducing serum phosphate in patients with end-stage renal disease under a contract with Shire, Prasco said Thursday.

August 8, 2013

Keryx Biopharmaceuticals announced the submission of a new drug application to the Food and Drug Administration seeking approval for the marketing and sale of Zerenex (ferric citrate coordination complex), the company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease on dialysis.

July 16, 2013

Diplomat Specialty Pharmacy is supporting a summer camp for children with chronic kidney disease, the company said Tuesday.

September 4, 2012

Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

June 28, 2012

Botanical Labs on Wednesday launched its certified gluten-free Protein Complete liquid dietary supplement that is fortified with 10 g of protein per 1-oz. serving.

June 7, 2012

The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

April 10, 2012

Biotech manufacturer Amgen will acquire the private South San Francisco, Calif.-based drug developer Kai Pharmaceuticals for $315 million, the companies said Tuesday.

March 28, 2012

The Food and Drug Administration has approved a new treatment for anemia in patients with chronic kidney disease.

April 22, 2011

An investigational antifibrotic and anti-inflammatory drug could help treat a common complication of diabetes.

March 7, 2011

Late-stage clinical trial data for a Keryx Biopharmaceuticals drug to treat kidney disease will be presented at a medical conference in Las Vegas.

February 25, 2011

Advances in kidney care have not led to successful efforts to improve therapy for patients with Type 1 diabetes, according to a study published in the Journal of the American Society of Nephrology.

February 8, 2011

The Food and Drug Administration has given expedited review to a drug for preventing hemodialysis failure in patients with end-stage kidney disease.

December 1, 2010

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

November 21, 2010

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

October 25, 2010

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

September 28, 2010

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

September 22, 2010

Drug makers Abbott and Reata Pharmaceuticals have signed an agreement concerning a drug for chronic...

February 1, 2010

Tiny areas of brain damage caused by injury to small blood vessels can signal an...